Prophylaxis against herpes labialis with acyclovir cream – a placebo-controlled study

J. R. Gibson, M. R. Klaber, S. G. Harvey, A. Tosti, D. Jones, J. M. Yeo

Research output: Contribution to journalArticle

32 Scopus citations

Abstract

Patients with 6 or more recurrences per year of herpes labialis were entered into a randomized, double-blind, placebo-controlled, crossover study. During the trial, they applied acyclovir cream for 16 weeks and placebo cream for 16 weeks to all previously affected areas 4 times per day, and were subsequently observed for further 16 weeks with no treatment. Results from the 23 evaluable cases showed that although recurrences did occur whilst on acyclovir treatment, patients suffered from significantly fewer days of disease and significantly fewer attacks of cold sores when compared with placebo.

Original languageEnglish (US)
Pages (from-to)104-107
Number of pages4
JournalDermatology
Volume172
Issue number2
DOIs
StatePublished - Jan 1 1986
Externally publishedYes

Keywords

  • Acyclovir cream
  • Prophylaxis against herpes labialis

ASJC Scopus subject areas

  • Dermatology

Fingerprint Dive into the research topics of 'Prophylaxis against herpes labialis with acyclovir cream – a placebo-controlled study'. Together they form a unique fingerprint.

Cite this